Renol Polychem IPO GMP Price Analysis, And Details
Renol Polychem IPO: Explore IPO GMP, price, date, allotment status, listing date, grey market premium, company financials, and other key details.

Renol Polychem IPO GMP Today, Price Band, Lot Size & Complete Details [2025]

India’s SME segment is witnessing a strong wave of listings, and Renol Polychem Ltd is the latest to enter the market with its Initial Public Offering (IPO). Known for its specialization in masterbatches, plastic additives, and polymer solutions, Renol Polychem’s IPO has drawn interest from both retail and institutional investors.

In this detailed post, we’ll explore the Renol Polychem IPO GMP, price band, lot size, issue size, IPO dates, and other key aspects. If you're looking to invest in an SME IPO with solid sector demand, this might be one to watch.

Company Introduction: Renol Polychem Limited

Incorporated in 2008, Renol Polychem Ltd operates in the polymer and plastic chemical industry, offering a wide range of high-quality masterbatches, pigments, and modifiers. The company primarily caters to UPVC and CPVC pipe manufacturers and plastic molding industries.

✅ Key Products:

  • Color Masterbatches: Including Red, Yellow, Green, Orange, Blue, Pink, Black, Multicolor, and more.

  • Filler Masterbatches: Based on calcium carbonate and talc, designed to reduce costs and enhance mechanical properties.

  • Polymer Additives: UV stabilizers, antioxidants, flame retardants, slip agents, and anti-block agents.

  • Impact Modifiers & Processing Aids: For enhanced durability, heat resistance, and flexibility of plastic products.

With a robust product portfolio and a growing customer base, Renol Polychem is well-positioned in a niche but essential sector that supports the construction, packaging, and plastic industries.

Renol Polychem IPO Details

The Renol Polychem IPO is an SME issue under the book-building route, offering a fresh issue of 24.54 lakh equity shares. The total issue size amounts to Rs. 25.77 Crores.

Particulars

Details

IPO Opening Date

31 July 2025

IPO Closing Date

04 August 2025

Issue Size

Rs. 25.77 Crores (24.54 lakh shares)

Offer for Sale (OFS)

Nil

Fresh Issue

Entirely Fresh Issue

Price Band

Rs. 100 – Rs. 105 per share

Face Value

Rs. 10 per share

Lot Size

1,200 shares

Minimum Investment

Rs. 1,26,000 (at upper price)

IPO Type

Book Built Issue

Listing Exchange

NSE SME Platform

Registrar

Skyline Financial Services Pvt. Ltd.

Market Maker

1,48,800 Shares (Rs. 1.56 Cr)

Expected Listing Date

07 August 2025

This SME IPO is fully a fresh issue, ensuring that the funds raised go directly into business expansion and capital strengthening.

Renol Polychem IPO GMP Today

As of 29 July 2025, the Renol Polychem IPO GMP (Grey Market Premium) is reported to be ₹9 per share. This means the estimated listing price could be around ₹114 per share (Upper band ₹105 + GMP ₹9), suggesting moderate bullishness in the grey market.

GMP reflects unofficial market sentiment and can give investors a sense of possible listing gains. However, it is essential to understand that GMP is speculative, unofficial, and subject to daily fluctuation. Always consider the company’s financials, business model, and sector outlook before making an investment based purely on GMP.

Objective of the IPO

The funds raised through this IPO will be utilized for:

  1. Working Capital Requirements: To support day-to-day operations, raw material procurement, and managing receivables.

  2. Business Expansion: Strengthening capacity, exploring new product lines, and entering new markets.

  3. Technology Upgrades: Enhancing manufacturing infrastructure and ensuring production efficiency.

  4. General Corporate Purposes: Brand building, administrative expenses, and financial restructuring.

The IPO aims to bolster Renol’s ability to serve a wider customer base while improving manufacturing capabilities.

Important IPO Dates: Renol Polychem IPO Timeline

Event

Date

IPO Open Date

31 July 2025

IPO Close Date

04 August 2025

Basis of Allotment

05 August 2025

Refund Initiation

06 August 2025

Demat Account Credit

06 August 2025

Expected Listing Date

07 August 2025

These dates are tentative and may be updated as per regulatory confirmations.

Why Consider Renol Polychem IPO?

Here are some reasons why the Renol IPO is creating interest in SME circles:

Sector Demand: The plastic and masterbatch industry is closely tied to construction, packaging, agriculture, and automotive sectors, showing consistent growth.

Diverse Product Portfolio: With a wide range of customized masterbatches and polymer solutions, Renol caters to multiple industrial requirements.

No OFS: The IPO does not include an Offer for Sale, meaning the entire proceeds go toward business development.

Growing Demand for Customization: Increased demand for durable, UV-resistant, and impact-resistant plastic products drives Renol’s core business.

SME Platform Listing: NSE SME listings often come with strong post-listening growth potential if backed by business fundamentals.

FAQs – Renol Polychem IPO GMP & Details

Q1. What is the Renol Polychem IPO GMP today?
As of 29 July 2025, the Renol Polychem IPO GMP is ₹9 per share. This may vary daily based on demand and sentiment.

Q2. What is the price band of the IPO?
The IPO is priced in a book-building range of Rs. 100 to Rs. 105 per share.

Q3. What is the minimum lot size and investment?
The lot size is 1,200 shares, requiring a minimum investment of Rs. 1,26,000 at the upper band.

Q4. What is the issue size of the IPO?
The total issue size is Rs. 25.77 Crores, consisting entirely of a fresh issue of 24.54 lakh shares.

Q5. When will the shares be listed?
The expected listing date is 07 August 2025, on the NSE SME platform.

Q6. Is there any offer for sale (OFS)?
No, this IPO includes only a fresh issue, meaning no existing shares are being sold by promoters.

Conclusion: Should You Apply for Renol Polychem IPO?

The Renol Polychem IPO offers a well-rounded opportunity to invest in India’s growing polymer and plastic additives industry. The company’s diverse product portfolio, absence of OFS, and expansion plans signal a growth-oriented outlook. Moreover, the


disclaimer

Comments

https://newyorktimesnow.com/public/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!